-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Monoclonal antibody therapy for classical Hodgkin lymphoma
Ewa Paszkiewicz-Kozik ,an Walewski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
South East Scotland Cancer Research Network: an opportunity to expand
Vivienne Wilson
Research Update: Clinical Investigation
-
South East Scotland Cancer Research Network: an opportunity to expand
Vivienne Wilson
Research Update: Clinical Investigation
-
South East Scotland Cancer Research Network: an opportunity to expand
Vivienne Wilson
Research Update: Clinical Investigation
-
South East Scotland Cancer Research Network: an opportunity to expand
Vivienne Wilson
Research Update: Clinical Investigation
-
South East Scotland Cancer Research Network: an opportunity to expand
Vivienne Wilson
Research Update: Clinical Investigation
-
South East Scotland Cancer Research Network: an opportunity to expand
Vivienne Wilson
Research Update: Clinical Investigation
-
South East Scotland Cancer Research Network: an opportunity to expand
Vivienne Wilson
Research Update: Clinical Investigation
-
South East Scotland Cancer Research Network: an opportunity to expand
Vivienne Wilson
Research Update: Clinical Investigation
-
GCP-compliant digital archiving of paper-based patient records of clinical trial subjects: a key issues paper
Christian D Kohl, Insa Bruns, Mathias Freudigmann, Guido Scharf, Paul Schmucker, Gabriele Schwarz, Sebastian C Semler
Clinical Trail Prospective: Clinical Investigation
-
GCP-compliant digital archiving of paper-based patient records of clinical trial subjects: a key issues paper
Christian D Kohl, Insa Bruns, Mathias Freudigmann, Guido Scharf, Paul Schmucker, Gabriele Schwarz, Sebastian C Semler
Clinical Trail Prospective: Clinical Investigation
-
GCP-compliant digital archiving of paper-based patient records of clinical trial subjects: a key issues paper
Christian D Kohl, Insa Bruns, Mathias Freudigmann, Guido Scharf, Paul Schmucker, Gabriele Schwarz, Sebastian C Semler
Clinical Trail Prospective: Clinical Investigation
-
GCP-compliant digital archiving of paper-based patient records of clinical trial subjects: a key issues paper
Christian D Kohl, Insa Bruns, Mathias Freudigmann, Guido Scharf, Paul Schmucker, Gabriele Schwarz, Sebastian C Semler
Clinical Trail Prospective: Clinical Investigation
-
GCP-compliant digital archiving of paper-based patient records of clinical trial subjects: a key issues paper
Christian D Kohl, Insa Bruns, Mathias Freudigmann, Guido Scharf, Paul Schmucker, Gabriele Schwarz, Sebastian C Semler
Clinical Trail Prospective: Clinical Investigation
-
GCP-compliant digital archiving of paper-based patient records of clinical trial subjects: a key issues paper
Christian D Kohl, Insa Bruns, Mathias Freudigmann, Guido Scharf, Paul Schmucker, Gabriele Schwarz, Sebastian C Semler
Clinical Trail Prospective: Clinical Investigation
-
GCP-compliant digital archiving of paper-based patient records of clinical trial subjects: a key issues paper
Christian D Kohl, Insa Bruns, Mathias Freudigmann, Guido Scharf, Paul Schmucker, Gabriele Schwarz, Sebastian C Semler
Clinical Trail Prospective: Clinical Investigation
-
GCP-compliant digital archiving of paper-based patient records of clinical trial subjects: a key issues paper
Christian D Kohl, Insa Bruns, Mathias Freudigmann, Guido Scharf, Paul Schmucker, Gabriele Schwarz, Sebastian C Semler
Clinical Trail Prospective: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation